Could This Biotech Start-Up Be the Next Moderna?
Moderna (NASDAQ: MRNA) has vaulted into the international spotlight more quickly and in a bigger way than arguably any biotech in history. There are probably many up-and-coming drugmakers that would love nothing more than to follow in Moderna's footsteps. Most of them won't be able to, of course. However, in this Motley Fool Live video recorded on May 12, Motley Fool contributors Keith Speights and Brian Orelli discuss a new biotech start-up that just might have a shot at becoming the next Moderna.
Source Fool.com